|
Volumn 1, Issue 6, 1999, Pages 466-467
|
Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ARTICLE;
BLOOD PRESSURE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
META ANALYSIS;
MORTALITY;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
CAPTOPRIL;
CEREBROVASCULAR ACCIDENT;
DIURETICS;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERTENSION;
META-ANALYSIS;
MYOCARDIAL INFARCTION;
PROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0033288410
PISSN: 15226417
EISSN: 15343111
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (17)
|
References (2)
|